Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ameya Life Sciences is an Indian biotechnology and pharmaceutical company focused on the development and manufacturing of high-quality vaccines and biological products. The company specializes in the production of essential immunizations, including vaccines for Hepatitis B, Rabies, and Tetanus, catering to both domestic and international markets. Ameya operates state-of-the-art manufacturing facilities that adhere to Good Manufacturing Practices (GMP) to ensure the safety and efficacy of its therapeutic offerings. By leveraging advanced bioprocessing technologies, the company aims to provide affordable healthcare solutions and improve public health outcomes in emerging economies. Ameya Life Sciences also engages in contract manufacturing and research services for global partners in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ameya Jasmin.